870 Followers on Owler
OverviewCompetitorsFundingInvestmentsNews & Insights

CTI BioPharma Competitors or Alternatives

CTI BioPharma's top competitors include Jakafi, BESREMi and INREBIC.

Unlock 12 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

CTI BioPharma's company profile

Adam R. Craig

President & CEO

83/100
100 - 250
$45.9M
$25M - 100M
  • $45.9M
    $25M - 100M
  • 100 - 250
    $45.9M
  • $25M - 100M
  • 83/100
  • 100 - 250
  • $45.9M
  • $25M - 100M
View ProfileView
1
CTI BioPharma's Competitor - Jakafi logo

CEO

- -
- -
  • - -
  • - -
  • - -
  • - -
View ProfileView
2
CTI BioPharma's Competitor - BESREMi logo

CEO

- -
- -
  • - -
  • - -
  • - -
  • - -
View ProfileView
3
CTI BioPharma's Competitor - INREBIC logo

CEO

- -
- -
  • - -
  • - -
  • - -
  • - -
View ProfileView
4
CTI BioPharma's Competitor - Kite Pharma logo

Suzy Suzanne Jefferson

Director

82/100
1,000 - 5,000
$634.9M
$500M - 1B
  • $634.9M
    $500M - 1B
  • 1,000 - 5,000
    $634.9M
  • $500M - 1B
  • 82/100
  • 1,000 - 5,000
  • $634.9M
  • $500M - 1B
View ProfileView
5
CTI BioPharma's Competitor - ArQule logo

Paolo Pucci

CEO

87/100
1 - 25
$55.2M
$5M - 25M
  • $55.2M
    $5M - 25M
  • 1 - 25
    $55.2M
  • $5M - 25M
  • 87/100
  • 1 - 25
  • $55.2M
  • $5M - 25M
View ProfileView
CTI BioPharma's top 15 competitors are Jakafi, BESREMi , INREBIC, Erytech, Kite Pharma, ArQule, Juno Therapeutics, Inovio, bluebird bio, Amgen, Jounce, Novartis, Agenus, AVROBIO and AbbVie. Together they have raised over 33.3B between their estimated 156.7K employees. CTI BioPharma's revenue is the ranked 9th among it's top 10 competitors. The top 10 competitors average 12.2B. CTI BioPharma has 128 employees and is ranked lowest among it's top 10 competitors. The top 10 competitors average 12,063.

Looking for similar companies to CTI BioPharma?

Similar Companies

Pharmaceuticals companies in Seattle

See 46 companies 
Biotechnology companies in Seattle

See 167 companies 
Pharmaceuticals companies in Seattle Metropolitan Area

See 102 companies 
Pharmaceuticals companies in Washington

See 188 companies 
Pharmaceuticals & Biotechnology companies in Seattle

See 194 companies 
Biotechnology companies in Seattle Metropolitan Area

See 258 companies 
Pharmaceuticals & Biotechnology companies in Seattle Metropolitan Area

See 328 companies 
Biotechnology companies in Washington

See 374 companies 
Pharmaceuticals & Biotechnology companies in Washington

See 510 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for CTI BioPharma and CTI BioPharma's Competitors

September 9, 2026BioCentury
BIOCENTURY | PRODUCT DEVELOPMENTNOVARTIS' PHASE III MISSES, PHARMA DEALS ANALYSIS, MFN CARVE-OUTS - A BIOCENTURY PODCASTPlus: A tribute to Peter Barton...
Today 2:34 PMBusiness Wire
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that a poster evaluating botensi...
September 8, 2026Benzinga
AMGN stock dips 9% after rival drug trial misses goal. Discover Amgen key support levels, technical outlook, and analyst price targetsread more...
September 8, 2026FinSMEs
Cloverleaf Bio, a New Haven, CT-based provider of engineered transfer RNA (tRNA) based payloads for cancer, raised $33M in Seed funding...
September 8, 2026CNBC
Novartis' failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer heart attacks and strokes....
September 9, 2026Investing.com
BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts...
Today 9:13 AMInvesting.com
HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review...
Today 1:19 PMSTAT News
A major Novartis shareholder has called for a shake-up of the drugmaker's board after its shares suffered a record fall following trial setbacks...
Today 2:54 PMPR Newswire
Menstrual migraine is a recurrent, debilitating migraine pattern, with attacks occurring around or during the menstrual period, a predictable time of i...
September 8, 2026Seeking Alpha

Frequently Asked Questions about CTI BioPharma

  1. Who are CTI BioPharma's top competitors?

    CTI BioPharma's top 3 competitors are Jakafi, BESREMi , INREBIC.

  2. Who is similar to CTI BioPharma?

    Jakafi is the most similar to CTI BioPharma. BESREMi and INREBIC are also similar to CTI BioPharma.

  1. Are CTI BioPharma and Jakafi competitors?

    Yes, Jakafi is one of CTI BioPharma’s top competitors.